ALVR
Price
$0.46
Change
+$0.01 (+2.22%)
Updated
Jan 6, 03:51 PM (EDT)
37 days until earnings call
XNCR
Price
$24.05
Change
-$0.07 (-0.29%)
Updated
Jan 6, 04:20 PM (EDT)
56 days until earnings call
Ad is loading...

ALVR vs XNCR

Header iconALVR vs XNCR Comparison
Open Charts ALVR vs XNCRBanner chart's image
AlloVir
Price$0.46
Change+$0.01 (+2.22%)
Volume$100
CapitalizationN/A
Xencor
Price$24.05
Change-$0.07 (-0.29%)
Volume$200
CapitalizationN/A
ALVR vs XNCR Comparison Chart
Loading...
ALVR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVR vs. XNCR commentary
Jan 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVR is a Hold and XNCR is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 06, 2025
Stock price -- (ALVR: $0.45 vs. XNCR: $24.13)
Brand notoriety: ALVR and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALVR: 25% vs. XNCR: 59%
Market capitalization -- ALVR: $52.48M vs. XNCR: $1.69B
ALVR [@Biotechnology] is valued at $52.48M. XNCR’s [@Biotechnology] market capitalization is $1.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $389.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVR’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • ALVR’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than ALVR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVR’s TA Score shows that 6 TA indicator(s) are bullish while XNCR’s TA Score has 6 bullish TA indicator(s).

  • ALVR’s TA Score: 6 bullish, 3 bearish.
  • XNCR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both ALVR and XNCR are a good buy in the short-term.

Price Growth

ALVR (@Biotechnology) experienced а -0.63% price change this week, while XNCR (@Biotechnology) price change was -0.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.35%. For the same industry, the average monthly price growth was +2.18%, and the average quarterly price growth was +7.68%.

Reported Earning Dates

ALVR is expected to report earnings on Feb 12, 2025.

XNCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($1.69B) has a higher market cap than ALVR($52.5M). ALVR YTD gains are higher at: 8.119 vs. XNCR (5.004). ALVR has higher annual earnings (EBITDA): -79.43M vs. XNCR (-198.91M). XNCR has more cash in the bank: 543M vs. ALVR (122M). ALVR has less debt than XNCR: ALVR (0) vs XNCR (86.6M). XNCR has higher revenues than ALVR: XNCR (85.2M) vs ALVR (0).
ALVRXNCRALVR / XNCR
Capitalization52.5M1.69B3%
EBITDA-79.43M-198.91M40%
Gain YTD8.1195.004162%
P/E RatioN/AN/A-
Revenue085.2M-
Total Cash122M543M22%
Total Debt086.6M-
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVRXNCR
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
69%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Ad is loading...
ALVR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMGRX143.911.41
+0.99%
Janus Henderson Enterprise I
GEMSX20.870.15
+0.72%
Goldman Sachs Emerging Markets Eq Svc
RMYAX9.290.04
+0.43%
Russell Inv Multi-Strategy Income A
FSSEX10.610.03
+0.28%
Fidelity SAI Sustainable Intl Eq
HRIDX12.040.03
+0.25%
Harbor Diversified Intl All Cp Admin

ALVR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALVR has been loosely correlated with MDGL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALVR jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVR
1D Price
Change %
ALVR100%
+0.91%
MDGL - ALVR
46%
Loosely correlated
+1.88%
XNCR - ALVR
38%
Loosely correlated
+1.43%
ATAI - ALVR
37%
Loosely correlated
+10.62%
SGMO - ALVR
37%
Loosely correlated
+15.04%
ERAS - ALVR
37%
Loosely correlated
+1.48%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RLAY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+1.43%
RLAY - XNCR
54%
Loosely correlated
+2.79%
VCYT - XNCR
52%
Loosely correlated
+3.64%
ERAS - XNCR
49%
Loosely correlated
+1.48%
AXON - XNCR
44%
Loosely correlated
+0.77%
BEAM - XNCR
43%
Loosely correlated
+2.75%
More